semaglutide and myasthenia gravis π§ β‘ (MG) Myasthenia gravis is an autoimmune disease affecting the neuromuscular junction, leading to fluctuating muscle weakness fatigability. πΉ Pathophysiology: Autoantibodies attack acetylcholine receptors at the neuromuscular Schematic diagram of the immunopathogenesis
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 10 - Aug 15
























